Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Single, Double and Triple Dose Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis: a Pilot Study
Conditions
Interventions
Single dose of Pentamidine
Two doses of Pentamidine
+1 more
Start Date
January 1, 2014
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
February 15, 2019
NCT03292835
NCT03837431
NCT04004754
Lead Sponsor
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions